Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Perinatal mortality | |||||
Systematic review |
28,208 pregnant women, not specifically those with unexplained recurrent miscarriage 20 RCTs in this analysis |
Perinatal mortality
2.9% with aspirin 20 mg to 150 mg daily 3.1% with placebo Absolute numbers not reported |
RR 0.92 95% CI 0.81 to 1.05 |
Not significant | |
Systematic review |
Pregnant women (number not reported), not specifically those with unexplained recurrent miscarriage 13 RCTs in this analysis |
Perinatal mortality
with aspirin up to 75 mg daily with placebo Absolute numbers not reported |
RR 0.92 95% CI 0.78 to 1.09 |
Not significant | |
Neonatal bleeding | |||||
Systematic review |
26,058 pregnant women, not specifically those with unexplained recurrent miscarriage 12 RCTs in this analysis |
Neonatal bleeding
1.8% with aspirin (any dose) 1.8% with placebo Absolute numbers not reported |
RR 1.03 95% CI 0.86 to 1.25 |
Not significant |